OncoFAP -GlyPro-MMAE is a FAP small molecule-drug conjugate (SMDC) with an IC 50 of 0.49 nM. OncoFAP -GlyPro-MMAE consists of a FAP Ligand OncoFAP ( HY-145938 ), a Tubulin inhibitor (MMAE) ( HY-15162 ) and a linker. OncoFAP -GlyPro-MMAE can be used for cancers like renal cancer research.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > FAP | Products > Signaling Pathways > Microtubule/Tubulin
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.